Sofia, Bulgaria, December 5, 2022 – According to the requirements of art. 100t of LPOS, “Sopharma” AD notifies that for November 2022 the Company recorded a decrease in sales of 6% compared to the same month of the previous year, incl. 8% decrease in domestic sales and 5% decrease in export sales.

For the eleven months since the beginning of the year the revenues from sales of products increase by 15%, incl. 10% increase of sales for the domestic market and 19% increase in export sales.